Ophthalmology

Top Story

Barrett Suite integrated into Zeiss’ IOLMaster 700

April 28, 2017

The Barrett Suite, which includes three new IOL power calculation formulas, has been fully integrated into the IOLMaster 700 for more accurate prediction of refractive outcomes, according to a Zeiss press release.

The IOLMaster 700 will automatically apply the Barrett Suite’s IOL power calculation formulas, which incorporate the influence of the posterior corneal surface and have been shown to be more accurate in predicting target refraction, the release said.

Nicox reports first quarter highlights

April 28, 2017
Nicox reported it had cash, cash equivalents and financial instruments totaling 25 million as of March 31 compared with 28.9 million as of Dec. 31, 2016, according to a…

Alcon introduces two vitreoretinal surgical technologies

April 28, 2017
Alcon is launching two vitreoretinal surgical products at the FLOREtina Retina Meeting in Florence, Italy, according to a press release. The Advanced Ultravit beveled…
Blog

BLOG: 2016 OWL award winners, part 2: What makes a rising star

April 28, 2017
What does it mean to receive the OWL 2016 Rising Star Award? What advice would you give other young ophthalmologists and industry leaders about moving the ophthalmic

Secondary analysis of DRCR.net Protocol T compares improvement and worsening rates over 2 years

April 27, 2017
A secondary analysis of DRCR.net Protocol T data demonstrated significant, sustained improvement rates of both nonproliferative and proliferative diabetic retinopathy at…
More News Headlines »
Clinical Science

Correlation Between Mesopic Retinal Sensitivity and Optical Coherence Tomographic Metrics of the Outer Retina in Patients With Non-Atrophic Dry Age-Related Macular Degeneration

Ophthalmic Surgery, Lasers and Imaging Retina, April 2017, Volume 48 Issue 4
To determine the correlation between mesopic retinal sensitivity and optical coherence tomographic metrics of the outer…
More »
CME

Glaucoma 2017: Controlling IOP and Promoting Adherence through Novel Therapeutics

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to…
More »
Featured
From OSN Europe Video
Meeting News

VIDEO: Astigmatism affects multifocal IOL models

February 20, 2017
More »
Advertisement
Advertisement